Isolation of cardiomyocytes, cardiac fibroblasts, and hepatocytes Murine neonatal cardiomyocytes and cardiac fibroblasts were prepared as described [2] , with some modifications. Briefly, hearts from 1-day-old C56BL/6 mice were obtained, washed in chilled Dulbecco's modified Eagle's medium (DMEM, Gibco, USA) and cut into 1 mm 3 pieces. The first digestion was discarded, in which the heart pieces were digested with trypsin/EDTA (Gibco, USA) at 4C for 30 min with rotation. After another 5-6 rounds of digestion with Liberase TH (0.1 U/ml in HBSS, Roche, Germany) at 37C for 10 min, the cell suspension was collected, filtered through a 70 µm cell strainer (BD, USA) and seeded onto fibronectin-coated 12-well tissue culture plates (Costar, USA) in DMEM supplemented with 20% fetal bovine serum (Gibco, USA) and antibiotics (50 mg/ml streptomycin, 50 U/ml penicillin) at 37°C in a 95% O2 and 5% CO2 incubator. Cardiac fibroblasts adhere more avidly to plastic than cardiomyocytes.
After 1 hour of incubation, cardiac fibroblasts attached tightly to the plates, whereas the cardiomyocytes-enriched suspension was collected, centrifuged, re-suspended and seeded onto another fibronectin-coated 12-well tissue culture plate. Thereafter, the isolated cardiomyocytes and cardiac fibroblasts were cultured separately for 48-72 hours. A high purity of cardiomyocytes (>90%) and cardiac fibroblasts (>95%) was confirmed using sarcomeric α-actinin (Boster immunoleader, USA) and vimentin (Sigma, USA) staining, respectively. Primary hepatocytes were isolated as described [3] . Briefly, male C57BL/6 mice aged 6-8 weeks were anesthetized intraperitoneally with 40 mg/kg sodium pentobarbital. After the portal vein was cannulated under aseptic conditions, the liver was perfused with Ethylene glycol bis (2-aminoethyl ether) tetraacetic acid and DMEM (Gibco, USA) and was digested with 0.075% collagenase (Roche, Germany). The isolated mouse hepatocytes were then cultured on mouse-tail collagen-coated plates for 24 hours.
Cell lines H5V endothelial cells from mouse heart were cultured as described [4] .
Confocal microscopic assay
Isolated cardiomyocytes and cardiac fibroblasts were plated onto glass slides, fixed in 4% paraformaldehyde and permeabilized with PBS containing 0.1% Triton X-100. After blocking with goat or mouse serum, double immunofluorescent staining on the slides was performed by incubating the samples with primary rat anti-IL-22R1 (R&D, USA) or anti-IL-10R2 (R&D, USA) and either mouse anti-sarcomeric α-actinin (Boster immunoleader, USA) or anti-vimentin (Sigma, USA); these antibodies were followed by incubations with secondary Cy3-conjugated anti-rat IgG (Proteintech, USA) and FITC-conjugated anti-mouse IgG (Proteintech, USA). Subsequently, cells were stained with 1 μg/ml DAPI to visualize the nuclei and viewed with a microscope.
RT-PCR
Total RNA was extracted from tissues or cultured cells with Trizol (Invitrogen, USA). RNA was reverse transcribed into cDNA using the PrimeScript RT reagent kit (Takara, Japan). The mRNA levels of genes were quantified using SYBR Green Master Mix (Takara, Japan) with the ABI PRISM StepOne TM system (Applied Biosystems, USA). Each reaction was performed in duplicate. The relative mRNA expression of target genes was normalized to β-ACTIN using the 2-∆∆CT method. Primer sequences are presented in supplemental Table S8 .
Western blot
Total protein extracts were isolated from tissues or cells with lysis buffer (M-PER Mammalian Protein Extraction Reagent, Pierce, USA) containing protease inhibitor cocktail (Roche, Germany). After centrifugation at 16000 g for 10 min at 4 °C, the supernatant was collected, and the total protein concentration was determined using a BCA Protein Assay Kit (Pierce, USA). A total of 30-50 μg protein was separated on a SDS-polyacrylamide gel and transferred to a nitrocellulose membrane and probed with antibodies against IL-22R1, IL-10 R2, AGP2 or β-klotho (all from R&D, USA); FGF21 (Aviva, USA); STAT1, phosphate STAT1, STAT3, phosphate STAT3, STAT5, phosphate STAT5, ERK, phosphate ERK, JNK, phosphate JNK, p38, phosphate p38, AKT, phosphate AKT, FGFR1 (all from Cell Signaling Technology, USA); FGFR2, FGFR3 or FGFR4 (all from Abcam, USA); or β-ACTIN (Santa Cruz Biotechnology, USA).
Immunoprecipitation
Cardiomyocytes were starved for 12 hours, stimulated with FGF21 (1 μg/ml, Biovendor, USA) for the indicated times and then lysed. Protein lysates (500 μg) were used for immunoprecipitation using the Pierce TM Crosslink IP kit (Thermo, USA). Briefly, protein lysates were immunoprecipitated using pre-cross-linked anti-FGFR1/2/3/4 antibody and protein A/G-Sepharose beads at 4°C overnight. The immunoprecipitates were washed with lysis buffer, eluted with Laemmli sample buffer and then subjected to immunoblotting analysis using anti-phosphotyrosine (Abcam, USA).
Microarray analysis
Total RNA was extracted from cardiomyocytes after exposure to hypoxia (in 2% oxygen, 5% CO2 and 93% N2) for 12 hours with or without FGF21 (1 μg/ml) using Trizol (Invitrogen,USA). Samples were processed for hybridization to the Mouse Gene 2.0 ST Array (Affymetrix). Prior to data analysis, all arrays referred to in this study were assessed for data quality using the Affymetrix Expression Console software v. 1.3 , and all quality assessment metrics (including spike-in controls during target preparation and hybridization) were found within boundaries. Genes showing 1.5 or greater fold changes with an adjusted value of p<0.05 are considered as differentially expressed. The data set has been deposited in Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE80199. Microarray data were also examined by gene set enrichment analysis (GSEA, http://software.broadinstitute.org/ gsea/ index.jsp) using the HALLMARK gene sets.
ELISA
Mouse IL-22 (BioLegend, USA), FGF21 (R&D, USA), and STAT3 (RayBiotech, USA) ELISA were performed according to the manufacturer's instructions.
Caspase-3 activity assay Caspase-3 activity was determined by the Caspase-3 activity assay kit (Beyotime, China) according to the manufacturer's instructions.
Supplemental Figure S1 IL-22R1 and IL-10R2 expression in the heart and heart resident cells. RT-PCR (A, B) and immunoblot analysis (C) determined the expression of IL-22R1 and IL-10R2 in the mouse heart, aorta, liver, and spleen. RT-PCR (D, E) and immunoblot analysis (F) determined the expression of IL-22R1 and IL-10R2 in cardiomyocytes, cardiac fibroblasts, cardiac microvascular endothelial cells (H5V), primary hepatocytes, and lymphocytes. (G) Representative confocal microscopy images of IL-22 R1 and IL-10R2 in cardiomyocytes and cardiac fibroblasts. Data represent at least three independent experiments. N.D.: not detectable.
Supplemental Figure S2 IL-22 administration dramatically increases plasma IL-22 levels. Plasma IL-22 levels were determined in unoperated mice and mice from Sham, MI, MI+Saline and MI+IL-22 groups at different time points after the operation. n=5 per group. N.D.: not detectable. **p<0.01 vs. MI+Saline group by one-way ANOVA.
Supplemental Figure S3 S3I-201 effectively inhibited phosphorylation of STAT3 in vivo. S3I-201 was administered intraperitoneally at a dose of 5 mg/kg 1 day prior to sham operation or coronary artery ligation. IL-22 was administered subcutaneously at a dose of 100 μg/kg immediately after the operation. STAT3 phosphorylation in the heart (A) and liver (B) was determined 1 hour after the operation by western blot. Data represent three independent experiments.
Supplemental Figure S4 IL-22 improved cardiac function in cardiac-specific STAT3 KO mice. Quantification of LVEDP, dp/dtmax, and dp/dtmin by hemodynamic analysis at 28 days after the operation. n=10 per group. *p<0.05 by one-way ANOVA.
Supplemental Figure S5 IL-22 failed to improve cardiac function in hepatic-specific STAT3 KO mice. Quantification of LVEDP, dp/dtmax, and dp/dtmin by hemodynamic analysis at 28 days after the operation. n=10 per group. *p<0.05 by one-way ANOVA.
Supplemental Figure S6 IL-22 increases liver FGF21 and AGP2 expression. RT-PCR determined the mRNA levels of AGP2, AGP3, CXCL13, FGF21, TFF3, LBP, NRG4, PRG4, BMPER and SAA2 in the liver at different time points post-MI between IL-22-and saline-treated mice. n=5 per group. *p<0.05 vs. MI+saline group by unpaired t test.
Supplemental Figure S7 IL-22 does not induce FGF21 expression in other tested organs and tissues besides liver. Relative mRNA FGF21 levels in heart, pancreas, kidney, brown/white adipose tissues, and skeletal muscle at different time points post-MI between IL-22 and saline-treated mice. n=5 per group. 
